Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Revenue projections:

Revenue projections for TORNTPHARM
Revenue projections for TORNTPHARM

Revenues for TORNTPHARM are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 0.00000
forwardPE 39.36155
debtToEquity 42.81000
earningsGrowth 0.19800
revenueGrowth 0.11200
grossMargins 0.75869
operatingMargins 0.26149
trailingEps 59.22000
forwardEps 0.00000

Positive earnings and revenue growth for TORNTPHARM suggest that the company is expected to grow its business. This trend reflects strong financial performance, with continued profitability and sales increases indicating a bright outlook for future expansion.
TORNTPHARM's positive gross and operating margins highlight its strong profitability. The company's ability to control costs while generating revenue indicates efficient operations and a healthy financial position.

Price projections:

Price projections for TORNTPHARM
Price projections for TORNTPHARM

Price projections for Torrent Pharmaceuticals Limited have been revised upward over time, signaling increasing optimism about the company's future. This steady increase reflects a positive outlook for Torrent Pharmaceuticals Limited's growth and market performance.

Insider Transactions:

Insider Transactions for TORNTPHARM
Insider Transactions for TORNTPHARM


1 transactions to buy Torrent Pharmaceuticals Limited occurred, with market price at 3224.449951171875.There were no buy transactions throughout the period under consideration.TORNTPHARM's current price levels have seen more selling than buying, which may indicate potential for further decline. If this trend continues, the stock could experience additional price drops, as selling pressure grows.

Recommendation changes over time:

Recommendations trend for TORNTPHARM
Recommendations trend for TORNTPHARM


Analysts are favoring TORNTPHARM with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider TORNTPHARM as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.